Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000668219 | SCV000792787 | uncertain significance | Polyglandular autoimmune syndrome, type 1 | 2017-07-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000710495 | SCV000840729 | uncertain significance | not provided | 2018-08-03 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000668219 | SCV004297413 | likely pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-10-26 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 8 of the AIRE protein (p.Arg8Cys). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with autosomal recessive autoimmune polyendocrinopathy syndrome (PMID: 17118990, 27253668). ClinVar contains an entry for this variant (Variation ID: 552873). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt AIRE protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Genomics England Pilot Project, |
RCV000668219 | SCV001760475 | pathogenic | Polyglandular autoimmune syndrome, type 1 | no assertion criteria provided | clinical testing |